| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Cost-effectiveness analysis of intranasal live attenuated vaccine (LAIV) versus injectable inactivated influenza vaccine (TIV) for Canadian children and adolescents. | Clinicoecon Outcomes Res | 2012 | 0.92 |
| 2 | A review of methods used in long-term cost-effectiveness models of diabetes mellitus treatment. | Pharmacoeconomics | 2010 | 0.92 |